Annual Report 2024–25
Ovarian Cancer Action has been at the heart of global ovarian cancer research for 40 years. Their 2024/25 annual report highlights major strides including the development of the world's first ovarian cancer vaccine, the launch of a new Global Research Consortium, and a high-profile Coronation Street partnership to raise symptom awareness. Their goal is for 50% of women to survive more than 10 years after diagnosis by 2032.
Report snapshot
264,000 people accessed the OCA website in 2024/25
Key Metric 1
Nearly 200,000 people reached through Ovarian Cancer Awareness Month campaign
Key Metric 2
Over 10,000 people completed the genetic risk tool
Key Metric 3
7
Views